OPCH

Health Services
$20.51 +2.19%
Back to Screener
Live Volume
2,646,479
Market Cap
3.22 B
P/E Ratio
16.05
52W Peak Proximity
%56

ANALYSIS CENTER

AI Rating & Analysis: OPCH stock analysis with hallucination-free AI screener tools — real-time price, volume, P/E ratio, 52-week proximity and sector performance data for Health Services. AI-powered stock analysis and research platform.
GOD-TIER PROMPT ACTIVE
Investment report at Goldman Sachs + Bridgewater + Renaissance Technologies level
10 sections: Tables • Charts • Bullet Points. Plain text PROHIBITED.
1Executive Summary
2Fair Value
3Fundamental Analysis
4Technical Analysis
5Scenario Analysis
6Competitor Comparison
7Dividend Return
8Risk Analysis
9Catalyst Calendar
10Action Plan
HOW IT WORKS: When you click an AI button below, this prompt is instantly copied to your clipboard. Simply Paste (CTRL+V) it into the chat box of the opened AI assistant to run the analysis.
İpucu: Tip: Use our TradingView charts for technical analysis. Evaluate alongside the AI report.
Open Advanced Chart
TradingView Charts
• 15-min delayed price feed • 100+ technical indicators • Sub-second updates • Professional drawing tools
Affiliate links — DocuRefinery may earn a commission when you open an account.

Interactive Brokers

SEC, FINRA, FCA, ASIC Regulation $0 Min. Deposit
Access 150+ global markets. Stocks, ETFs, Options, Futures, Forex.
Open Account

TD Ameritrade (Schwab)

SEC, FINRA Regulation $0 Min. Deposit
Industry-leading trading platforms and comprehensive education.
Open Account
All investing involves risk, including the possible loss of principal. Past performance does not guarantee future results.

Latest News — OPCH

Option Care Health, Inc. — Company Profile & Analysis

Option Care Health, Inc. stands as a preeminent provider of comprehensive home and alternate site infusion services across the United States. While its specific founding date is not publicly detailed in all sources, the company has evolved into a national leader through a strategic blend of organic growth and key acquisitions, notably the merger with BioScrip in 2019, which solidified its market position. At its core, Option Care Health is driven by a mission to deliver high-quality, cost-effective, and patient-centric care outside the traditional hospital environment. This approach not only enhances patient convenience and comfort but also aims to improve clinical outcomes and reduce overall healthcare expenditures by shifting complex treatments to more accessible and less costly settings. The company's foundational philosophy centers on empowering patients to manage their health conditions effectively from the familiarity of their homes, supported by expert clinical teams.

The breadth of Option Care Health's service portfolio is extensive, encompassing a wide array of specialized infusion therapies and support services designed to address numerous acute and chronic conditions. Key offerings include anti-infective therapy, critical home infusion services for heart failure management, and comprehensive home parenteral and enteral nutrition support for conditions such as stroke, cancer, and gastrointestinal diseases. The company is also a significant provider of immunoglobulin infusion therapies for immune deficiencies and offers treatments for a spectrum of chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health provides therapies to manage the progression of complex neurological disorders like Duchenne muscular dystrophy, multiple sclerosis, and Alzheimer's disease, alongside infusion therapies for bleeding disorders such as hemophilia and von Willebrand diseases. Specialized care for women with high-risk pregnancies, pain management, chemotherapy, and respiratory medications, complemented by professional nursing services, rounds out its robust service lines, demonstrating a commitment to holistic patient care.

Strategically positioned as a leader in the rapidly expanding U.S. home and alternate site infusion market, Option Care Health boasts a significant national footprint, serving patients across diverse geographies. Its market penetration is primarily achieved through a robust referral network, cultivated over years with key stakeholders in the healthcare ecosystem. This network includes physicians, hospital discharge planners, hospital personnel, health maintenance organizations (HMOs), and preferred provider organizations (PPOs), all of whom recognize the value and efficacy of home-based infusion care. The company's target demographics are broad, encompassing patients of all ages who require complex, long-term, or specialized infusion therapies that can be safely and effectively administered outside of an inpatient setting. Headquartered in Bannockburn, Illinois, Option Care Health maintains a strong operational focus within the United States, leveraging its centralized management and distributed clinical teams to ensure consistent, high-quality service delivery nationwide.

Looking ahead, Option Care Health is poised for continued growth, driven by several macro trends within the healthcare industry. The increasing demand for value-based care, coupled with an aging population and a persistent focus on cost containment, strongly favors the expansion of home-based medical services. The company's strategic direction involves further enhancing its clinical capabilities, expanding its therapeutic offerings, and investing in technological innovations to optimize patient management, improve adherence, and streamline operational efficiencies. This includes leveraging data analytics for better patient outcomes and exploring new digital health solutions to support remote monitoring and patient engagement. Option Care Health aims to solidify its position as the partner of choice for complex infusion care, continuously adapting to evolving healthcare needs and regulatory landscapes, thereby ensuring sustainable long-term growth and delivering superior value to patients, providers, and shareholders alike.

Economic Moat Option Care Health's sustainable competitive advantage stems from its extensive national network and specialized infrastructure, enabling the delivery of complex, high-acuity infusion therapies directly to patients' homes across the United States. This is further bolstered by deep clinical expertise and a highly trained nursing staff capable of managing a wide range of intricate medical conditions, fostering strong trust and long-term relationships with both patients and critical referral sources like physicians and hospitals. The company's ability to navigate complex logistics, manage specialized pharmaceutical supply chains, and integrate seamlessly into the broader healthcare ecosystem creates significant barriers to entry for potential competitors.
CEO Mr. John Charles Rademacher
Employees 6,528
Headquarters United States
Market Competitors
Smart Tags
#HealthcareServices #HomeInfusion #SpecialtyPharmacy #PatientCare #USHealthcare #MedicalServices #AlternateSiteCare #OPCH

Market Insights & Investor Q&A — OPCH

Frequently Asked Questions

Which ready-made template can I use to evaluate dividend stability for the OPCH stock?
DocuRefinery offers a ready-made template that measures dividend stability; just enter the OPCH ticker and receive an instant AI-driven analysis. It is free, no signup required, and uses verified data.
How do I create an instant AI prompt to uncover hidden market trends for OPCH?
Select the instant prompt option on the platform, specify OPCH, and the AI scans recent volume and price movements to reveal trend signals, delivering results within seconds.
Why is using a professional financial modeling prompt advantageous for OPCH?
A ready prompt automates complex modeling steps, reduces data errors, and provides hallucination‑free outcomes. Access it for free without registration and shrink analysis time from hours to minutes.

Deep Analysis

AI-Powered Ready Solutions for OPCH Investment Analysis

When analyzing stocks like OPCH, AI methodologies bring speed to risk assessment and trend detection. DocuRefinery’s pre-built prompts instantly scan balance sheet data, flagging potential risks and opportunities.

Traditional analysis often requires hours of data gathering and model building, whereas AI‑driven ready solutions deliver the same insights in minutes. Users can retrieve OPCH’s price volatility, liquidity profile, and sector comparisons with a single command, all based on verified data and guaranteed hallucination‑free results.

Prompt engineering with AI lets investors craft customized analysis strategies. Building a tailored risk‑return profile for OPCH takes just a few lines of prompt, enabling faster, more reliable investment decisions.